Net income fell to €240 million from €452 million in the second quarter of 2024. Income from operations declined to €400 ...

President Trump announced a U.S.–EU framework deal on Sunday. The agreement includes a 15% tariff on EU goods entering the U.S., down from the 30% originally proposed. Markets welcomed the clarity but ...

Investing.com-- Most Asian stock markets fell on Tuesday, led by declines in Japan and Hong Kong, as investors turned cautious ahead of the approaching U.S. tariff deadline and braced for key central ...

Brent Oil Futures expiring in September inched up 0.1% to $70.09 a barrel by 21:53 ET (01:53 GMT), while U.S. West Texas Intermediate (WTI) crude futures were muted at $66.74 per barrel. Both ...

Investing.com -- GBank Financial Holdings Inc. (NASDAQ: GBFH) shares tumbled 5.4% after the company reported second quarter earnings that fell short of analyst expectations, despite posting record ...

Brown & Brown’s results come as the company prepares for its pending acquisition of RSC Topco, Inc., with approximately $13 million of interest income earned from proceeds of the company’s follow-on ...

Investing.com -- Loandepot Inc (NYSE: LDI) stock rose 3.6% after the company announced that founder Anthony Hsieh has been appointed permanent Chief Executive Officer, effective immediately. Hsieh had ...

Investing.com -- Ranger Energy Services Inc (NYSE: RNGR) stock surged 5.9% in afterhours trading following the company’s announcement of its first Hybrid Double Electric Workover Rig development, ...

Investing.com -- Dyne Therapeutics, Inc. (NASDAQ: DYN) reported a second quarter loss that slightly missed analyst expectations as the clinical-stage biotech company continues to advance its ...

NEW YORK - CNO Financial Group (NYSE: CNO) reported second-quarter adjusted earnings that slightly exceeded analyst expectations, as the company continues to make progress toward its 2025-2027 return ...

Investing.com -- PTC (NASDAQ: PTC) Therapeutics (NASDAQ: PTCT) stock rose 9% after the company announced that the U.S. Food and Drug Administration (FDA) has approved its drug SEPHIENCE (sepiapterin) ...

Investing.com -- Metsera , Inc. (NASDAQ: MTSR ), a clinical-stage biopharmaceutical company focused on obesity and metabolic diseases, reported a wider-than-expected second quarter loss on Monday, ...